Oral Abstracts Session
Virtual Recording
Ann P. Laube, MSc
Scientific Associate
Charité – Universitätsmedizin Berlin
Berlin, Berlin, Germany
Ann P. Laube, MSc
Scientific Associate
Charité – Universitätsmedizin Berlin
Berlin, Berlin, Germany
Sarah Nordmeyer, MD
Physician
University Hospital Tübingen
Tübingen, Baden-Wurttemberg, Germany
Titus Kühne, MD
Head of the Institute of Computer-assisted Cardiovascular Medicine
Deutsches Herzzentrum der Charité
Berlin, Berlin, Germany
Frank Edelmann, MD
Physician
Charité – Universitätsmedizin Berlin, Berlin, Germany
Djawid Hashemi, MD, MSc
Cardiologist
Deutsches Herzzentrum der Charité, Berlin, Germany
Sebastian Kelle, MD, PhD, FSCMR
Cardiologist
Deutsches Herzzentrum der Charité
Berlin, Berlin, Germany
Philipp Mertins, PhD
Head of Proteomics Platform
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Berlin, Berlin, Germany
Anja Hennemuth, PhD
Prof.
Deutsches Herzzentrum der Charité, Germany
| Control | Cluster A | Cluster B | p (A vs B)† | |||
| Women | Men | Women | Men | Women | Men |
|
n | 19 | 20 | 40 |
| |||
Scanner | 1.5 T Philips Achieva, five-element cardiac phased-array coil |
| |||||
Flip Angle ° | 15 | 15 | 15 |
| |||
Slice Thickness mm | 10 | 7 | 7 |
| |||
Repetition Time ms | 3.688 | 3.786 ± 0.112 | 3.841 ± 0.063 |
| |||
Echo Time ms | 2.207 | 2.300 ± 0.112 | 2.358 ± 0.063 |
| |||
Venc cm/s | 250 | 600 | 600 |
| |||
Pixel Spacing mm | 1.367 | 1.208 ± 0.051 | 1.219 ± 0.001 |
| |||
Sex (male) | 10 (53%) | 5 (25%) | 31 (77.5%) | 0.0002* | |||
Age years | 62 ± 8 | 65 ± 10 | 67 ± 9 | 0.5249 | |||
59 ± 8 | 65 ± 8 | 67 ± 8 | 59 ± 13 | 70 ± 5 | 66 ± 10 |
| |
BSA m2 | 1.90 ± 0.23 | 1.76 ± 0.12 | 2.07 ± 0.18 | < 0.00001* | |||
1.73±0.13 | 2.05±0.20 | 1.72± 0.10 | 1.90±0.07 | 1.98±0.14 | 2.10±0.18 |
| |
AAo Area mm2 | 896 ± 235 | 1033 ± 323 | 813 ± 235 | 0.0077* | |||
887 ± 241 | 903 ± 242 | 940 ± 198 | 1311±479 | 639 ±215 | 864 ± 219 |
| |
LVEF % | 64.4 ± 5.2 | 60.2 ± 7.0 | 56.1 ± 9.0 | 0.0436* | |||
66.3 ± 5.2 | 62.1± 4.3 | 60.7 ± 6.9 | 58.6 ± 7.8 | 60.6 ±8.1 | 54.7 ± 8.9 |
| |
EDVi ml/m2 | 64.4 ± 11.2 | 72.0 ± 19.6 | 83.4 ± 24.8 | 0.0918 | |||
| 58.6±9.9 | 71.9±8.2 | 69.0±17.1 | 80.9±25.9 | 86.3±16.4 | 87.6±25.3 |
|
ESVi ml/m2 | 23.3 ±6.0 | 29.4 ± 11.6 | 37.9 ± 33.2 | 0.0518 | |||
| 20.0±5.5 | 27.4±3.9 | 27.9±11.1 | 34.0±13.4 | 27.9±11.7 | 40.8±18.0 |
|
NT-pro-BNP ng/l | 88.7 ± 61.1 | 356.8 ± 238.2 | 996.0 ± 1015.2 | 0.0226* | |||
| 120±70 | 60.2±34.7 | 408±244 | 168±58 | 846±569 | 1028±1092 |
|
Troponin -T ng/l | 7.1 ± 3.4 | 7.8 ± 4.3 | 13.9 ± 6.8 | 0.0020* | |||
| 7.1 ± 4.3 | 7.1 ± 2.6 | 7.6 ± 4.7 | 8.3 ± 3.5 | 10.7 ± 7.6 | 14.5 ± 6.6 |
|
Ventricular Scarring |
| 0 | 9 (22.5%) | 0.0179* | |||
BAV |
| 18 (90%) | 25 (62.5%) | 0.0340* | |||
Valve calcification |
| 1 (5%) | 4 (10%) | 0.6563 | |||
a. BSA and Ascending Aortic cross section area, stratified by flow profile cluster and sex. Cluster A contains predominantly women, cluster B mostly men, while women of high BSA and low AAo area are in cluster A, and men with low BSA and high AAo area in cluster B. b. Log2 of protein LFQ intensity of serpinE2 and STAT3, proteins identified in previous studies [3] to be involved in cardiac fibrosis and remodelling.